Cyclopentadecanone → N-Cyclopentadecyl-N-(3-pyridylmethyl)amine

HRID 327922

Reaktionsgleichung

[NH2:1][CH2:2][C:3]1[CH:4]=[N:5][CH:6]=[CH:7][CH:8]=1.[C:9]1(=O)[CH2:23][CH2:22][CH2:21][CH2:20][CH2:19][CH2:18][CH2:17][CH2:16][CH2:15][CH2:14][CH2:13][CH2:12][CH2:11][CH2:10]1>>[CH:9]1([NH:1][CH2:2][C:3]2[CH:4]=[N:5][CH:6]=[CH:7][CH:8]=2)[CH2:23][CH2:22][CH2:21][CH2:20][CH2:19][CH2:18][CH2:17][CH2:16][CH2:15][CH2:14][CH2:13][CH2:12][CH2:11][CH2:10]1

Komponenten

Edukt 2

HCID 10409Cyclopentadecanone

HCID 310183-Pyridinemethanamine

Produkt 1

HCID 14800148N-Cyclopentadecyl-N-(3-pyridylmethyl)amine

Versuchsvorschrift

Following the general procedure of Example 33, but starting with 3-aminomethylpyridine and cyclopentadecanone, the title compound is produced, NMR (CDCl3, TMS) δ8.58, 7.72, 7.25, 3.76, 2.56, 1.32.

Quellen und Nachweise

ORD-Eintrag: ord-4b7dd28525f44c4fb17831940432ddbb
Quelldatensatz: uspto-grants-1993_12
DOI: 10.6084/m9.figshare.5104873.v1
Patentnummer: US05274089

Verknüpfte Notizen

Wird geladen…